Elizabeth Arden, Inc. (RDEN) Posts Surprise Q3 Profit; Affirms Outlook
Tweet
Share
E-mailGet Alerts RDEN Hot Sheet
Price: $13.98 --0%
Financial Fact:
Income from operations: -14.38M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Income from operations: -14.38M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Elizabeth Arden, Inc. (NASDAQ: RDEN) reported Q3 EPS of $0.02, $0.08 better than the analyst estimate of ($0.06). Revenue for the quarter came in at $231.3 million versus the consensus estimate of $226.57 million.
Affirms outlook
Affirms outlook
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Birchtech Corp. (BCHT) Misses Q2 EPS by 7c
- Eledon Pharmaceuticals, Inc. (ELDN) Misses Q2 EPS by 12c
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
